Fragrance avoidance
No fragrance-linked caution surfaced in the current profile.
This ingredient does not currently read as a fragrance-linked driver in the published evidence and hazard profile.
EPA CPDat observed this chemical in 1279 composition records across product categories including Construction and building materials, Furniture and furnishings, Construction.
Concern score
The concern value reflects this ingredient's chemical identity — its hazard profile from the published classifications and regulatory status below — not the safety of a product it appears in. A score near 40 is the baseline for ingredients with no specific signal (water scores 40 by design), so a mid-range value is not a safety verdict.
Concern score 5/100 · limited confidence.
Prevalence of POLYETHYLENE GLYCOL 400 in our catalog (epa_cpdat).
Products
1,279
Brands
6
Typical roles
Catalog
Co-occurrence
Ingredients that frequently appear alongside POLYETHYLENE GLYCOL 400 in the catalog.
Context-specific fit derived from published classifications and the current ingredient evidence profile.
Fragrance avoidance
No fragrance-linked caution surfaced in the current profile.
This ingredient does not currently read as a fragrance-linked driver in the published evidence and hazard profile.
The published evidence profile currently shaping this ingredient record.
Primary documents currently linked to this ingredient record.
Structured claim signals pulled from linked ingredient research.
Published jurisdiction-level classifications and regulatory designations for this ingredient.
US
EPA
EPA CPDat observed this chemical in 1279 composition records across product categories including Construction and building materials, Furniture and furnishings, Construction. EPA CPDat classifies this chemical for functional uses including Solvent, Binder, Processing aids not otherwise specified.
US
FDA
Route: ORAL; Dosage form: CONCENTRATE; Potency: 100 mg/1ml
US
FDA
Cool Wave
Gillette
Route: ORAL; Dosage form: SOLUTION; Potency: 1000 mg/5ml
US
FDA
Route: ORAL; Dosage form: TABLET, FILM COATED; Potency: 1.52 mg
US
FDA
Route: RECTAL; Dosage form: SUPPOSITORY; Potency: 1658 mg
US
FDA
Route: TOPICAL; Dosage form: AEROSOL, FOAM; Potency: NA
US
FDA
Route: TOPICAL; Dosage form: GEL; Maximum daily exposure: 50 mg
US
FDA
Route: TRANSDERMAL; Dosage form: GEL; Potency: 0.5 %w/w
US
FDA
Route: ORAL; Dosage form: CAPSULE, EXTENDED RELEASE; Maximum daily exposure: 91 mg
US
FDA
Route: ORAL; Dosage form: SOLUTION; Maximum daily exposure: 6108 mg
US
FDA
Route: ORAL; Dosage form: SUSPENSION; Maximum daily exposure: 4000 mg
US
FDA
Route: ORAL; Dosage form: TABLET, EXTENDED RELEASE; Maximum daily exposure: 9 mg
US
FDA
Route: ORAL; Dosage form: TABLET, FILM COATED; Potency: 0.13 mg
US
FDA
Route: TOPICAL; Dosage form: OINTMENT; Maximum daily exposure: 921 mg
US
FDA
Route: URETHRAL; Dosage form: SUPPOSITORY; Potency: 9.75 mg
US
FDA
Route: RECTAL; Dosage form: SUPPOSITORY; Potency: 0.3 mg/mg
US
FDA
Route: TOPICAL; Dosage form: SOLUTION; Potency: 29.7 %w/w
US
FDA
Route: AURICULAR (OTIC); Dosage form: DROPS; Potency: 9.98 %w/w
US
FDA
Route: ORAL; Dosage form: SOLUTION; Maximum daily exposure: 1440 mg
US
FDA
Route: TOPICAL; Dosage form: OINTMENT; Potency: 39 %w/w
US
FDA
Route: ORAL; Dosage form: CAPSULE; Maximum daily exposure: 108 mg
US
FDA
Route: ORAL; Dosage form: TABLET; Maximum daily exposure: 17 mg
US
FDA
Route: ORAL; Dosage form: TABLET, DELAYED RELEASE; Potency: 0.01 mg
US
FDA
Route: ORAL; Dosage form: TABLET; Maximum daily exposure: 1 mg
US
FDA
Route: INTRA-ARTICULAR; Dosage form: INJECTION; Maximum daily exposure: 56 mg
US
FDA
Route: INTRA-ARTICULAR; Dosage form: INJECTION, SUSPENSION; Maximum daily exposure: 56 mg
US
FDA
Route: INTRALESIONAL; Dosage form: INJECTION, SUSPENSION; Maximum daily exposure: 87 mg
US
FDA
Route: INTRAMUSCULAR; Dosage form: INJECTION; Maximum daily exposure: 56 mg
US
FDA
Route: INTRAMUSCULAR; Dosage form: INJECTION, SUSPENSION; Maximum daily exposure: 87 mg
US
FDA
Route: INTRAMUSCULAR; Dosage form: INJECTION, SUSPENSION, EXTENDED RELEASE; Maximum daily exposure: 60 mg
US
FDA
Route: INTRASYNOVIAL; Dosage form: INJECTION; Potency: 3 %w/v
US
FDA
Route: INTRASYNOVIAL; Dosage form: INJECTION, SUSPENSION; Maximum daily exposure: 87 mg
US
FDA
Route: INTRAVENOUS; Dosage form: INJECTION; Potency: 0.5 ml
US
FDA
Route: NASAL; Dosage form: SPRAY, METERED; Maximum daily exposure: 96 mg
US
FDA
Route: ORAL; Dosage form: CAPSULE; Maximum daily exposure: 576 mg
US
FDA
Route: ORAL; Dosage form: CAPSULE, EXTENDED RELEASE; Maximum daily exposure: 51 mg
US
FDA
Route: ORAL; Dosage form: SUSPENSION; Maximum daily exposure: 900 mg
US
FDA
Route: ORAL; Dosage form: SUSPENSION, EXTENDED RELEASE; Maximum daily exposure: 37 mg
US
FDA
Route: ORAL; Dosage form: TABLET; Maximum daily exposure: 52 mg
US
FDA
Route: ORAL; Dosage form: TABLET, CHEWABLE; Potency: 15 mg
US
FDA
Route: ORAL; Dosage form: TABLET, COATED; Potency: 0.5 mg
US
FDA
Route: ORAL; Dosage form: TABLET, DELAYED RELEASE; Maximum daily exposure: 10 mg
US
FDA
Route: ORAL; Dosage form: TABLET, EXTENDED RELEASE; Maximum daily exposure: 61 mg
US
FDA
Route: ORAL; Dosage form: TABLET, FILM COATED; Potency: 20 mg
US
FDA
Route: ORAL; Dosage form: TABLET, ORALLY DISINTEGRATING; Potency: 0.16 mg
US
FDA
Route: RECTAL; Dosage form: SUPPOSITORY; Maximum daily exposure: 5704 mg
US
FDA
Route: SOFT TISSUE; Dosage form: INJECTION, SUSPENSION; Maximum daily exposure: 87 mg
US
FDA
Route: SUBCUTANEOUS; Dosage form: INJECTION, SUSPENSION; Potency: 2.88 %w/v
US
FDA
Route: SUBCUTANEOUS; Dosage form: SUSPENSION; Potency: 2.88 %w/v
US
FDA
Route: TOPICAL; Dosage form: CREAM; Maximum daily exposure: 396 mg
US
FDA
Route: TOPICAL; Dosage form: OINTMENT; Maximum daily exposure: 1179 mg
US
FDA
Route: INTRAMUSCULAR; Dosage form: INJECTION; Potency: 20.3 %w/v
US
FDA
Route: INTRAMUSCULAR; Dosage form: INJECTION, SOLUTION; Potency: 20.3 %w/v
US
FDA
Route: INTRAVENOUS; Dosage form: INJECTION; Maximum daily exposure: 28216 mg
US
FDA
Route: INTRAVENOUS; Dosage form: INJECTION, SOLUTION; Maximum daily exposure: 24186 mg
US
FDA
Route: NASAL; Dosage form: SPRAY, METERED; Maximum daily exposure: 320 mg
US
FDA
Route: OPHTHALMIC; Dosage form: SOLUTION; Maximum daily exposure: 46 mg
US
FDA
Route: OPHTHALMIC; Dosage form: SOLUTION/ DROPS; Potency: 1 %w/v
US
FDA
Route: ORAL; Dosage form: CAPSULE; Maximum daily exposure: 13440 mg
US
FDA
Route: ORAL; Dosage form: CAPSULE, DELAYED RELEASE; Maximum daily exposure: 26 mg
US
FDA
Route: ORAL; Dosage form: CAPSULE, EXTENDED RELEASE; Maximum daily exposure: 17 mg
US
FDA
Route: ORAL; Dosage form: CAPSULE, LIQUID FILLED; Maximum daily exposure: 1122 mg
US
FDA
Route: ORAL; Dosage form: CONCENTRATE; Maximum daily exposure: 3000 mg
US
FDA
Route: ORAL; Dosage form: FILM, SOLUBLE; Maximum daily exposure: 29 mg
US
FDA
Route: ORAL; Dosage form: SOLUTION; Maximum daily exposure: 70200 mg
US
FDA
Route: ORAL; Dosage form: SOLUTION, CONCENTRATE; Maximum daily exposure: 2813 mg
US
FDA
Route: ORAL; Dosage form: SUSPENSION; Maximum daily exposure: 400 mg
US
FDA
Route: ORAL; Dosage form: SYRUP; Maximum daily exposure: 740 mg
US
FDA
Route: ORAL; Dosage form: TABLET; Maximum daily exposure: 193 mg
US
FDA
Route: ORAL; Dosage form: TABLET, DELAYED RELEASE; Maximum daily exposure: 35 mg
US
FDA
Route: ORAL; Dosage form: TABLET, EXTENDED RELEASE; Maximum daily exposure: 60 mg
US
FDA
Route: ORAL; Dosage form: TABLET, FILM COATED, EXTENDED RELEASE; Maximum daily exposure: 2 mg
US
FDA
Route: ORAL; Dosage form: TABLET, ORALLY DISINTEGRATING; Maximum daily exposure: 2 mg
US
FDA
Route: RECTAL; Dosage form: SUPPOSITORY; Potency: 0.25 mg/mg
US
FDA
Route: TOPICAL; Dosage form: AEROSOL, POWDER; Potency: NA
US
FDA
Route: TOPICAL; Dosage form: EMULSION; Potency: 1.2 %w/w
US
FDA
Route: TOPICAL; Dosage form: GEL; Maximum daily exposure: 6300 mg
US
FDA
Route: TOPICAL; Dosage form: OINTMENT; Maximum daily exposure: 1950 mg
US
FDA
Route: TOPICAL; Dosage form: SOLUTION; Maximum daily exposure: 11100 mg
US
FDA
Route: TOPICAL; Dosage form: SWAB; Maximum daily exposure: 5250 mg
US
FDA
Route: VAGINAL; Dosage form: GEL; Maximum daily exposure: 1250 mg
US
FDA
Route: VAGINAL; Dosage form: SUPPOSITORY; Potency: 30 mg
US
FDA
Route: INTRA-ARTICULAR; Dosage form: INJECTION; Potency: 3 %w/v
US
FDA
Route: INTRAMUSCULAR; Dosage form: INJECTION; Potency: 3 %w/v
US
FDA
Route: INTRAMUSCULAR; Dosage form: INJECTION, SUSPENSION, EXTENDED RELEASE; Maximum daily exposure: 375 mg
US
FDA
Route: INTRAVENOUS; Dosage form: INJECTION, POWDER, FOR SUSPENSION; Maximum daily exposure: 24 mg
US
FDA
Route: ORAL; Dosage form: CAPSULE; Maximum daily exposure: 1659 mg
US
FDA
Route: ORAL; Dosage form: CAPSULE, DELAYED RELEASE; Potency: 1.28 mg
US
FDA
Route: ORAL; Dosage form: CAPSULE, EXTENDED RELEASE; Potency: 10.72 mg
US
FDA
Route: ORAL; Dosage form: GRANULE; Maximum daily exposure: 83 mg
US
FDA
Route: ORAL; Dosage form: SOLUTION; Maximum daily exposure: 2667 mg
US
FDA
Route: ORAL; Dosage form: TABLET; Maximum daily exposure: 83 mg
US
FDA
Route: ORAL; Dosage form: TABLET, COATED; Potency: 2 mg
US
FDA
Route: ORAL; Dosage form: TABLET, DELAYED RELEASE; Maximum daily exposure: 90 mg
US
FDA
Route: ORAL; Dosage form: TABLET, EXTENDED RELEASE; Maximum daily exposure: 433 mg
US
FDA
Route: ORAL; Dosage form: TABLET, FILM COATED; Maximum daily exposure: 5 mg
US
FDA
Route: RECTAL; Dosage form: SUPPOSITORY; Potency: 1269 mg
US
FDA
Route: SUBLINGUAL; Dosage form: TABLET; Potency: 2.5 mg
US
FDA
Route: TOPICAL; Dosage form: OINTMENT; Potency: 45 %w/w
US
FDA
Route: ORAL; Dosage form: CAPSULE; Maximum daily exposure: 18 mg
US
FDA
Route: ORAL; Dosage form: CAPSULE, EXTENDED RELEASE; Maximum daily exposure: 53 mg
US
FDA
Route: ORAL; Dosage form: TABLET; Maximum daily exposure: 60 mg
US
FDA
Route: ORAL; Dosage form: CAPSULE; Maximum daily exposure: 3600 mg
US
FDA
Route: ORAL; Dosage form: CAPSULE, DELAYED RELEASE; Maximum daily exposure: 35 mg
US
FDA
Route: ORAL; Dosage form: CAPSULE, DELAYED RELEASE PELLETS; Maximum daily exposure: 135 mg
US
FDA
Route: ORAL; Dosage form: CAPSULE, EXTENDED RELEASE; Maximum daily exposure: 302 mg
US
FDA
Route: ORAL; Dosage form: TABLET; Maximum daily exposure: 750 mg
US
FDA
Route: ORAL; Dosage form: TABLET, COATED; Potency: 106 mg
US
FDA
Route: ORAL; Dosage form: TABLET, DELAYED RELEASE; Maximum daily exposure: 120 mg
US
FDA
Route: ORAL; Dosage form: TABLET, EXTENDED RELEASE; Maximum daily exposure: 250 mg
US
FDA
Route: ORAL; Dosage form: TABLET, FILM COATED; Maximum daily exposure: 132 mg
US
FDA
Route: ORAL; Dosage form: TABLET, ORALLY DISINTEGRATING, DELAYED RELEASE; Maximum daily exposure: 69 mg
US
FDA
Route: RECTAL; Dosage form: SUPPOSITORY; Potency: 128 mg
US
FDA
Route: SUBLINGUAL; Dosage form: TABLET; Potency: 70 mg
US
FDA
Route: OPHTHALMIC; Dosage form: SOLUTION; Potency: 2 %w/w
US
FDA
Route: ORAL; Dosage form: CAPSULE; Maximum daily exposure: 180 mg
US
FDA
Route: ORAL; Dosage form: CAPSULE, EXTENDED RELEASE; Maximum daily exposure: 98 mg
US
FDA
Route: ORAL; Dosage form: TABLET; Maximum daily exposure: 1200 mg
US
FDA
Route: ORAL; Dosage form: TABLET, CHEWABLE; Potency: 6.5 mg
US
FDA
Route: ORAL; Dosage form: TABLET, COATED; Potency: 0.21 mg
US
FDA
Route: ORAL; Dosage form: TABLET, DELAYED RELEASE; Maximum daily exposure: 29 mg
US
FDA
Route: ORAL; Dosage form: TABLET, EXTENDED RELEASE; Maximum daily exposure: 242 mg
US
FDA
Route: ORAL; Dosage form: TABLET, FILM COATED; Potency: 49 mg
US
FDA
Route: ORAL; Dosage form: TABLET, FILM COATED, EXTENDED RELEASE; Potency: 14 mg
US
FDA
Route: ORAL; Dosage form: TABLET, ORALLY DISINTEGRATING; Maximum daily exposure: 1 mg
US
FDA
Route: ORAL; Dosage form: TABLET, ORALLY DISINTEGRATING, DELAYED RELEASE; Maximum daily exposure: 8 mg
US
FDA
Route: RECTAL; Dosage form: SUPPOSITORY; Maximum daily exposure: 208 mg
US
FDA
Route: SUBLINGUAL; Dosage form: FILM; Maximum daily exposure: 24 mg
US
FDA
Route: TOPICAL; Dosage form: CREAM; Maximum daily exposure: 361 mg
US
FDA
Route: TOPICAL; Dosage form: SOLUTION; Potency: 0.95 %w/w
US
FDA
Route: ORAL; Dosage form: FILM, SOLUBLE; Maximum daily exposure: 52 mg
US
FDA
Route: ORAL; Dosage form: TABLET, EXTENDED RELEASE; Maximum daily exposure: 385 mg
US
FDA
Route: SUBLINGUAL; Dosage form: FILM; Maximum daily exposure: 18 mg
US
FDA
Route: ORAL; Dosage form: TABLET, EXTENDED RELEASE; Maximum daily exposure: 672 mg
US
FDA
Route: ORAL; Dosage form: CAPSULE, EXTENDED RELEASE; Maximum daily exposure: 32 mg
US
FDA
Route: ORAL; Dosage form: FILM, SOLUBLE; Maximum daily exposure: 107 mg
US
FDA
Route: ORAL; Dosage form: TABLET, EXTENDED RELEASE; Maximum daily exposure: 463 mg
US
FDA
Route: SUBLINGUAL; Dosage form: FILM; Maximum daily exposure: 41 mg
US
FDA
Route: ORAL; Dosage form: TABLET; Maximum daily exposure: 140 mg
US
FDA
Route: ORAL; Dosage form: TABLET, EXTENDED RELEASE; Maximum daily exposure: 550 mg
US
FDA
Route: ORAL; Dosage form: TABLET, EXTENDED RELEASE; Maximum daily exposure: 335 mg
US
FDA
Route: ORAL; Dosage form: CAPSULE, EXTENDED RELEASE; Potency: 89 mg
US
FDA
Route: ORAL; Dosage form: TABLET, EXTENDED RELEASE; Maximum daily exposure: 936 mg
US
FDA
Route: ORAL; Dosage form: TABLET, EXTENDED RELEASE; Maximum daily exposure: 189 mg
US
FDA
Route: ORAL; Dosage form: TABLET; Maximum daily exposure: 735 mg
US
FDA
Route: ORAL; Dosage form: TABLET, EXTENDED RELEASE; Maximum daily exposure: 740 mg
US
FDA
Route: ORAL; Dosage form: TABLET, EXTENDED RELEASE; Maximum daily exposure: 1287 mg
US
FDA
FDA NDC lists this ingredient in 116 active drug products and 120 total products.
US
FDA
FDA NDC lists this ingredient in 1 active drug products and 1 total products.
US
FDA
FDA NDC lists this ingredient in 125 active drug products and 131 total products.
US
FDA
openFDA substance registry classifies this ingredient as polymer.
US
FDA
openFDA substance registry classifies this ingredient as concept.
US
FDA
openFDA substance registry classifies this ingredient as mixture.